Notice of Change: Extension of PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)" by one Council Round
Notice Number:
NOT-NS-24-020

Key Dates

Release Date:
December 01, 2023

Related Announcements

  • November 30, 2023- Notice of Change: Extension of PAR-22-028 "Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)" by one Council Round. See Notice NOT-NS-24-035.
  • November 9, 2021 - Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional). See NOFO PAR-22-030.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to inform applicants of an extension to PAR-22-030"Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)". The NOFO will be extended by one additional council round. Due to the extension, the following dates have been added: New, Resubmission, Revision due date: October 10, 2024. Expiration date October 11, 2024. Changes to the NOFO are shown below.

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

December 22, 2021December 22, 2021Not ApplicableMarch 2022May 2022July 2022
February 09, 2022February 09, 2022Not ApplicableJuly 2022October 2022December 2022
June 09, 2022June 09, 2022Not ApplicableNovember 2022January 2023April 2023
October 08, 2022October 08, 2022Not ApplicableMarch 2023May 2023July 2023
February 09, 2023February 09, 2023Not ApplicableJuly 2023October 2023December 2023
June 09, 2023June 09, 2023Not ApplicableNovember 2023January 2024April 2024
October 10, 2023October 10, 2023Not ApplicableMarch 2024May 2024July 2024
February 08, 2024February 08, 2024Not ApplicableJuly 2024October 2024December 2024
June 07, 2024June 07, 2024Not ApplicableNovember 2024January 2025April 2025


Expiration Date: June 8, 2024

Modified to Read:

Part 1. Overview Information

Key Dates

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

December 22, 2021December 22, 2021Not ApplicableMarch 2022May 2022July 2022
February 09, 2022February 09, 2022Not ApplicableJuly 2022October 2022December 2022
June 09, 2022June 09, 2022Not ApplicableNovember 2022January 2023April 2023
October 08, 2022October 08, 2022Not ApplicableMarch 2023May 2023July 2023
February 09, 2023February 09, 2023Not ApplicableJuly 2023October 2023December 2023
June 09, 2023June 09, 2023Not ApplicableNovember 2023January 2024April 2024
October 10, 2023October 10, 2023Not ApplicableMarch 2024May 2024July 2024
February 08, 2024February 08, 2024Not ApplicableJuly 2024October 2024December 2024
June 07, 2024June 07, 2024Not ApplicableNovember 2024January 2025April 2025
October 10, 2024October 10, 2024Not ApplicableMarch 2025May 2025July 2025


Expiration Date: October 11, 2024

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Chris Boshoff, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]